Paresh Thakker

1.6k total citations
25 papers, 918 citations indexed

About

Paresh Thakker is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Paresh Thakker has authored 25 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Paresh Thakker's work include Cytokine Signaling Pathways and Interactions (5 papers), IL-33, ST2, and ILC Pathways (4 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Paresh Thakker is often cited by papers focused on Cytokine Signaling Pathways and Interactions (5 papers), IL-33, ST2, and ILC Pathways (4 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). Paresh Thakker collaborates with scholars based in United States, United Kingdom and Japan. Paresh Thakker's co-authors include Suzana Marušić, John P. Leonard, Michael W. Leach, Stephen Benoit, Jeffrey W. Pelker, Joy Miyashiro, James D. Clark, Junqing Cui, Marina W. H. Shen and Daniel L. Comins and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Analytical Biochemistry.

In The Last Decade

Paresh Thakker

25 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paresh Thakker United States	15	360	310	133	120	112	25	918
Krikor Bijian Canada	22	169 0.5×	553 1.8×	122 0.9×	162 1.4×	166 1.5×	40	1.2k
Yoko Yamagiwa Japan	17	222 0.6×	404 1.3×	110 0.8×	214 1.8×	146 1.3×	38	1.0k
Marcella Marcellini Italy	15	164 0.5×	405 1.3×	192 1.4×	107 0.9×	98 0.9×	16	905
Guihua Jin China	17	248 0.7×	429 1.4×	62 0.5×	176 1.5×	166 1.5×	35	937
Fusako Nishigaki Japan	19	141 0.4×	469 1.5×	159 1.2×	183 1.5×	120 1.1×	41	1.0k
Ivo Nnane United States	17	186 0.5×	359 1.2×	84 0.6×	95 0.8×	47 0.4×	46	1.0k
Yanyang Zhao China	18	453 1.3×	918 3.0×	164 1.2×	98 0.8×	184 1.6×	37	1.2k
Sühendan Ekmekçioğlu United States	15	221 0.6×	403 1.3×	50 0.4×	278 2.3×	139 1.2×	22	839
Johannes Kreuzer United States	15	242 0.7×	801 2.6×	203 1.5×	277 2.3×	188 1.7×	25	1.5k
Krishnendu Roy United States	16	508 1.4×	450 1.5×	37 0.3×	118 1.0×	158 1.4×	25	1.0k

Countries citing papers authored by Paresh Thakker

Since Specialization

Citations

This map shows the geographic impact of Paresh Thakker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paresh Thakker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paresh Thakker more than expected).

Fields of papers citing papers by Paresh Thakker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paresh Thakker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paresh Thakker. The network helps show where Paresh Thakker may publish in the future.

Co-authorship network of co-authors of Paresh Thakker

This figure shows the co-authorship network connecting the top 25 collaborators of Paresh Thakker. A scholar is included among the top collaborators of Paresh Thakker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paresh Thakker. Paresh Thakker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krueger, James G., Sandra Garcet, Sanjay Kumar, et al.. (2024). 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis. Journal of Investigative Dermatology. 144(8). S46–S46. 1 indexed citations

Boeckxstaens, Guy E., Sabry Ayad, George E. Dukes, et al.. (2024). A randomized phase 2 study of the 5-HT4 receptor agonist felcisetrag for postoperative gastrointestinal dysfunction after bowel surgery. The American Journal of Surgery. 234. 162–171. 1 indexed citations

Krueger, James G., Jie Cheng, Wenwen Zhang, et al.. (2024). 50378 Clinical efficacy of TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, is associated with modulation of disease and TYK2 pathway biomarkers in patients with moderate-to-severe psoriasis. Journal of the American Academy of Dermatology. 91(3). AB159–AB159. 2 indexed citations

Wang, Claire Q., Sokol Haxhinasto, Sandra Garcet, et al.. (2022). Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis. Journal of Investigative Dermatology. 143(1). 87–97.e14. 12 indexed citations

Rasmussen, Daniel Guldager Kring, Quentin M. Anstee, Richard Torstenson, et al.. (2022). NAFLD and NASH biomarker qualification in the LITMUS consortium – Lessons learned. Journal of Hepatology. 78(4). 852–865. 20 indexed citations

Reuveni, Debby, Eli Brazowski, Patrick S.C. Leung, et al.. (2021). Interleukin 23 Produced by Hepatic Monocyte-Derived Macrophages Is Essential for the Development of Murine Primary Biliary Cholangitis. Frontiers in Immunology. 12. 718841–718841. 14 indexed citations

Bianchi, Andrea, Tanja Schönberger, Ernest Raymond, et al.. (2016). Noninvasive Longitudinal Study of a Magnetic Resonance Imaging Biomarker for the Quantification of Colon Inflammation in a Mouse Model of Colitis. Inflammatory Bowel Diseases. 22(6). 1286–1295. 8 indexed citations

Kasaian, Marion T., Karen Page, Susan Fish, et al.. (2014). Therapeutic activity of an interleukin‐4/interleukin‐13 dual antagonist on oxazolone‐induced colitis in mice. Immunology. 143(3). 416–427. 42 indexed citations

Thakker, Paresh, Suzana Marušić, Nancy Stedman, et al.. (2011). Cytosolic Phospholipase A2α Blockade Abrogates Disease during the Tissue-Damage Effector Phase of Experimental Autoimmune Encephalomyelitis by Its Action on APCs. The Journal of Immunology. 187(4). 1986–1997. 13 indexed citations

10.

Ramarao, Manjunath, Marina W. H. Shen, Elizabeth Murphy, et al.. (2008). Thermodynamic characterization of cytosolic phospholipase A2 alpha inhibitors. Analytical Biochemistry. 383(2). 217–225. 6 indexed citations

11.

Marušić, Suzana, Paresh Thakker, Jeffrey W. Pelker, et al.. (2008). Blockade of cytosolic phospholipase A2α prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses. Journal of Neuroimmunology. 204(1-2). 29–37. 51 indexed citations

12.

Thakker, Paresh, et al.. (2007). IL-23 Is Critical in the Induction but Not in the Effector Phase of Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 178(4). 2589–2598. 137 indexed citations

13.

McKew, John C., Megan A. Foley, Paresh Thakker, et al.. (2006). Inhibition of Cytosolic Phospholipase A 2 α: Hit to Lead Optimization. 10 indexed citations

14.

Marušić, Suzana, Michael W. Leach, Jeffrey W. Pelker, et al.. (2005). Cytosolic phospholipase A2α–deficient mice are resistant to experimental autoimmune encephalomyelitis. The Journal of Experimental Medicine. 202(6). 841–851. 123 indexed citations

15.

Cui, Junqing, Joy Miyashiro, Paresh Thakker, et al.. (2005). TH1-mediated airway hyperresponsiveness independent of neutrophilic inflammation. Journal of Allergy and Clinical Immunology. 115(2). 309–315. 56 indexed citations

16.

McKew, John C., Megan A. Foley, Paresh Thakker, et al.. (2005). Inhibition of Cytosolic Phospholipase A₂α: Hit to Lead Optimization. Journal of Medicinal Chemistry. 49(1). 135–158. 63 indexed citations

17.

Singh, Satyendra, Mukul R. Jain, Hardik Shah, et al.. (2004). Direct injection, column switching–liquid chromatographic technique for the estimation of rabeprazole in bioequivalence study. Journal of Chromatography B. 813(1-2). 247–254. 35 indexed citations

18.

Lavigne, Mark C., Paresh Thakker, Jason R. Gunn, et al.. (2004). Human bronchial epithelial cells express and secrete MMP-12. Biochemical and Biophysical Research Communications. 324(2). 534–546. 53 indexed citations

19.

Kaila, Neelu, et al.. (2001). Design and synthesis of sialyl lewis x mimics as e-selectin inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(2). 151–155. 20 indexed citations

20.

Padmanabhan, Seetharamaiyer, Paresh Thakker, Lu Zhang, et al.. (2001). Solution-Phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockers. Bioorganic & Medicinal Chemistry Letters. 11(24). 3151–3155. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact